SpecialtyRx Prepares FDA Approved COVID Bivalent Booster - SpecialtyRx
September 22, 2022
SpecialtyRx Prepares FDA Approved COVID Bivalent Booster

SpecialtyRx gears up for flu and COVID seasons with new COVID bivalent booster,

What you need to know:

  • The newest FDA approved bivalent booster is a single dose
  • Pfizer’s bivalent is approved for 12 and older
  • Moderna’s bivalent is approved for 18 and older
  • Moderna and Pfizer are compatible with each other
  • Monovalent vaccines can only be used for primary series 1st and 2nd doses
  • Bivalent booster must be given 2 months after primary series is complete or 2 months after the last COVID booster was administered
  • Flu and COVID vaccines can be administered simultaneously

“SpecialtyRx is fully prepared with plenty of stock on the Pfizer bivalent. Our teams have already sent new clinic cover sheets, guideline packets and consent forms to all of our clients in preparation for vaccine administration ahead of the high risk seasons and we continue to do all vaccine reporting to immunization registries,” stated Saba Ansari, Pharm.D – VP of Clinical Services.